| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 87346 |
Benzyl-PEG2-CH2CO2H(CAS号:93206-09-8) |
112 |
WYQ |
2024-12-12 |
| 87347 |
Benzyl-PEG3-CH2CO2tBu(CAS号:1643957-26-9) |
172 |
WYQ |
2024-12-12 |
| 87348 |
cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
153 |
zcy |
2024-12-12 |
| 87349 |
Benzyl-PEG2-CH2CO2tBu(CAS号:1309451-06-6) |
139 |
WYQ |
2024-12-12 |
| 87350 |
1191064-81-9,Fmoc-NH-PEG9-CH2CH2COOH,5,8,11,14,17,20,23,26,29-九氧杂-2-氮杂三十二碳二酸 1-(9H-芴-9-基甲基)酯 |
149 |
kx |
2024-12-12 |
| 87351 |
cas:77855-75-5,PEG5-(CH2CO2H)2 |
152 |
zcy |
2024-12-12 |
| 87352 |
Benzyl-PEG6-CH2CO2tBu(CAS号:1807537-31-0) |
178 |
WYQ |
2024-12-12 |
| 87353 |
1245823-50-0,Propargyl-PEG4-CH2CH2-Boc,丙炔基-四聚乙二醇-丙酸叔丁酯 |
214 |
kx |
2024-12-12 |
| 87354 |
Benzyl-PEG5-CH2CO2tBu(CAS号:1807503-89-4) |
124 |
WYQ |
2024-12-12 |
| 87355 |
MAK683-CH2CH2COOH hydrochloride的物理与化学性质 |
149 |
kx |
2024-12-12 |
| 87356 |
Ald-benzyl-PEG4-CH2 tBu-ester,cas:2421119-25-5 |
191 |
zyl |
2024-12-12 |
| 87357 |
Benzyl-PEG4-CH2CO2tBu(CAS号:1443467-88-6) |
161 |
WYQ |
2024-12-12 |
| 87358 |
m-PEG6-(CH2)6-Phosphonic acid,2028284-71-9 |
136 |
wyh |
2024-12-12 |
| 87359 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3的功能与用途 |
170 |
kx |
2024-12-12 |
| 87360 |
Ald-CH2-PEG3-azide,1002342-83-7 |
225 |
wyh |
2024-12-12 |
| 87361 |
73168-24-8,(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin,(d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 |
154 |
kx |
2024-12-12 |
| 87362 |
Thalidomide-5-O-CH2-COO(t-Bu),2682112-10-1 |
198 |
wyh |
2024-12-12 |
| 87363 |
Tos-PEG3-CH2CO2tBu(CAS号:882518-89-0) |
158 |
WYQ |
2024-12-12 |
| 87364 |
Tos-PEG7-CH2CO2tBu(CAS号:1530777-90-2) |
157 |
WYQ |
2024-12-12 |
| 87365 |
cas:391684-36-9,t-Boc-N-amido-PEG6-CH2CO2H |
132 |
zcy |
2024-12-12 |
| 87366 |
173414-89-6,m-C-tri(CH2-PEG1-NHS ester) |
139 |
kx |
2024-12-12 |
| 87367 |
Tos-PEG3-CH2CO2H(CAS号:1807537-35-4) |
256 |
WYQ |
2024-12-12 |
| 87368 |
(±)-Bupropion-(CH2)3-OH hydrochloride,(±)-安非他酮-(CH2)3-OH盐酸盐 |
176 |
wyh |
2024-12-12 |
| 87369 |
Tos-PEG2-CH2CO2tBu(CAS号:1643957-24-7) |
177 |
WYQ |
2024-12-12 |
| 87370 |
cas:2100306-71-4,Bromo-PEG3-CH2CO2tBu |
180 |
zcy |
2024-12-12 |
| 87371 |
1835759-71-1,Azido-PEG4-(CH2)3-methyl ester |
148 |
kx |
2024-12-12 |
| 87372 |
Tos-PEG6-CH2CO2tBu(CAS号:1949793-62-7) |
192 |
WYQ |
2024-12-12 |
| 87373 |
cas:635287-26-2,Fmoc-NH-PEG5-CH2COOH |
159 |
zcy |
2024-12-12 |
| 87374 |
cas:2304558-22-1,t-butyl ester-PEG5-CH2COOH |
158 |
zcy |
2024-12-12 |
| 87375 |
Tos-PEG5-CH2CO2tBu(CAS号:169751-73-9) |
206 |
WYQ |
2024-12-12 |
| 87376 |
cas:102013-72-9,m-PEG9-CH2COOH |
168 |
zcy |
2024-12-12 |
| 87377 |
2112737-70-7,m-PEG8-(CH2)12-phosphonic acid ethyl ester |
159 |
kx |
2024-12-12 |
| 87378 |
(d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin的功能与用途 |
171 |
kx |
2024-12-12 |
| 87379 |
(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin |
168 |
kx |
2024-12-12 |
| 87380 |
cas:2100306-54-3,Ald-CH2-PEG4-CH2CO2tBu |
237 |
zcy |
2024-12-12 |
| 87381 |
2353410-05-4,Ald-CH2-PEG10-Boc |
167 |
kx |
2024-12-12 |
| 87382 |
Thalidomide-NH-CH2-COO(t-Bu)的分子结构特点 |
214 |
kx |
2024-12-12 |
| 87383 |
1047997-31-8,Difluorocyclooctyne-CH2-COOH,化合物 DIFLUOROCYCLOOCTYNE-CH2-COOH |
267 |
kx |
2024-12-12 |
| 87384 |
Aminooxy-PEG4-CH2CO2tBu(CAS号:2062663-62-9) |
172 |
WYQ |
2024-12-12 |
| 87385 |
2914227-54-4,NH2-PEG4-GGFG-NH-CH2-O-CH2COOH |
164 |
kx |
2024-12-12 |
| 87386 |
t-Boc-Aminooxy-PEG2-CH2CO2H(CAS号:2098983-14-1) |
164 |
WYQ |
2024-12-12 |
| 87387 |
Hydroxy-PEG2-(CH2)2-Boc的主要用途 |
184 |
kx |
2024-12-12 |
| 87388 |
t-Boc-Aminooxy-PEG4-CH2CO2H(CAS号:2028281-90-3) |
166 |
WYQ |
2024-12-12 |
| 87389 |
Tos-PEG5-CH2CO2H(CAS号:2028284-73-1) |
185 |
WYQ |
2024-12-12 |
| 87390 |
Mal-(CH2)5-Val-Cit-PAB-Eribulin,2130869-21-3 |
158 |
wyh |
2024-12-12 |